Metformin Prolongs Survival in Type 2 Diabetes Lung Cancer Patients With EGFR-TKIs

Background: Metformin use reportedly reduces cancer risk and improves survival in lung cancer patients. This study aimed to investigate the effect of metformin use in patients with diabetes mellitus (DM) and lung cancer receiving epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI)...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Integr Cancer Ther
Main Authors: Hung, Ming-Szu, Chuang, Min-Chun, Chen, Yi-Chuan, Lee, Chuan-Pin, Yang, Tsung-Ming, Chen, Pau-Chung, Tsai, Ying-Huang, Yang, Yao-Hsu
Formato: Artigo
Idioma:Inglês
Publicado: SAGE Publications 2019
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6696848/
https://ncbi.nlm.nih.gov/pubmed/31409137
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1534735419869491
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares